Search
for

    Sort by

    Research 511–540 of 1000+

    1. Dermatitis cruris pustulosa et atrophicans Indian journal of dermatology, venereology, and leprology · 2009 · 11 citations
    2. The evolution of three generations of platelet concentrates products: a leap from classical formulations to the era of extracellular vesicles Frontiers in Bioengineering and Biotechnology · 2025 · 6 citations
    3. Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 3 citations
    4. Inflammatory auxo-action in the stem cell division theory of cancer PeerJ · 2023 · 2 citations
    5. Rethinking serotonin’s role in mental health C&EN Global Enterprise · 2026
    6. Effects of COVID-19 and Its Vaccination on Bullous Pemphigoid Updates in clinical dermatology · 2025
    7. Overview of COVID-19 and Its Vaccination and Its Relation to Dermatology Updates in clinical dermatology · 2025
    8. Commercial and Open‐Source Systems 2024
    9. Clinical guidelines of ukrainian hair research society. diagnosis and treatment of alopecia areata Aktualʹnì problemi sučasnoï medicini · 2023
    10. Tingkat Stres dan Pencapaian Kompetensi Mahasiswa Program Profesi Dokter: Penelitian Kuantitatif dan Kualitatif 2023
    11. Elisabeth & Antonio: Hotel Las Arenas Wedding 2014
    12. Vitamin Treatment Offers Little Hope for Gray Hair The Science News-Letter · 1942
    13. Anti-Gray Hair Vitamin Succeeds in Human Subjects The Science News-Letter · 1941
    14. Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network Oncotarget · 2017 · 18 citations
    15. Platelet-Rich Plasma for Hair Loss Springer eBooks · 2021 · 12 citations
    16. Alopecia and Semaglutide: Connecting the Dots for Patient Safety Journal of Cosmetic Dermatology · 2025 · 4 citations
    17. A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System Pharmacology Research & Perspectives · 2025 · 2 citations
    18. Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network Expert Opinion on Drug Safety · 2024 · 1 citations
    19. Hair loss in the era of CGRP inhibition: emerging evidence, mechanisms, and clinical implications Frontiers in Neurology · 2026
    20. Response to: “finasteride prescribed for hair loss consistently leads to depression” Postgraduate Medicine · 2026
    21. 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata Journal of Investigative Dermatology · 2026
    22. 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization Journal of the American Academy of Dermatology · 2026
    23. Low-Dose Oral Minoxidil Beyond Androgenetic Alopecia: A Comparative Narrative Review of Emerging Evidence JAAD reviews. · 2026
    24. The Role of Glucagon-Like Peptide-1 Receptor Agonists in Hair Loss: Clinical Evidence and Proposed Mechanisms Dermatologic Surgery · 2026
    25. Effects of GLP ‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review International Journal of Dermatology · 2025
    26. Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system The Journal of Sexual Medicine · 2025
    27. Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System International Journal of Dermatology · 2025
    28. Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports Pharmaceuticals · 2025
    29. Xerostomia as a rare adverse effect of low-dose oral minoxidil: a case report with recurrence after re-challenge 2025
    30. Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications Journal of the European Academy of Dermatology and Venereology · 2025